- Shopping Bag ( 0 items )
From the Publisher"In this accessible text Fisher critically examines the National Drug Control Strategy (NDCS) of the past ten years and observes that it has failed to reduce either the supply of drugs or the demand for them in the U.S. He then considers in turn a number of controversial issues such as the legalization of marijuana and the disease concept of addiction. He concludes by proposing a new model for an NDCS that is based on harm management."
Reference & Research Book News
"Offering a comprehensive presentation of relevant data, Fisher details past and current failures of the US's National Drug Control Strategy (NDCS). His most convincing and important contention is that the emphasis on reducing marijuana use among youth is misguided. Youth alcohol consumption, argues Fisher, causes far more harm than marijuana use, and alcohol is most often the gateway drug to other drugs and hence to drug problems. In a discussion that echoes criticism of big tobacco, the author exposes the alcohol industry's efforts to attract young drinkers to replace drinkers who are aging or dead, and he points to evidence that the NDCS—and the nation's laws regarding drug use, including alcohol—is heavily influenced by lobbying from alcohol interests. As a result, objective evidence that conflicts with alcohol interests is dismissed. This is a fascinating book….Essential. All readers; all levels."
"He approaches his topic, the critical review of the National Drug Control Strategies, with an organized, well-developed case based on published data. Fisher dismantles the strategies implemented for the last decade in minute detail, and leaves the reader with a picture of a government throwing enormous amounts of money at drug control strategies that, at their best, are demonstrated to be only adequate or passable when outcome measures are applied….[a] quick and informative read for anyone interested in substance abuse and intervention strategies in the United States. The author's presentation of data points unerringly to the failure of the drug control strategies that we have invested in so heavily since 1996. A change is clearly called for, and Fisher makes a compelling case for such a change."